Model-informed Drug Development Intensive Interactive Courses

November 16-20, 2026 | ONLINE The ABC of modelling drug transporter data: Mechanistic approaches to predict the impact of drug transport proteins on ADME, Pharmacokinetics, and Toxicity Overview: This course provides a dynamic mixture of lectures, demonstrations and hands-on exercises providing a wide-array of theory and practical know how. Live demonstrations of the simulation platforms essential for consideration in developing PBPK models with transporters are given, which will facilitate the attendees learning, driven through hands-on sessions to be attempted remotely. The hands-on sessions will be re-visited the following day with the tutors providing guidance, troubleshooting tips and facilitating interactive Q&A on the exercises. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more

November 16-20, 2025 | ONLINE This course broadens the range and utilization of in silico-based mechanistic prediction and analysis of drug absorption after oral delivery, including the development of mechanistic physiologically based in vitro-in vivo correlations (IVIVCs), virtual bioequivalence (VBE) concepts, and application of biopharmaceutic IVIVE using the SIVA Toolkit.  We strongly recommend attending Oral Absorption I before taking this workshop. Read more

Clinical Applications of Endogenous Biomarkers using PBPK  Tutors: Matt Harwood, Aneesh Karkhanis, Jakub Witkowski, Xian Pan Date: November 16-20, 2026 | ONLINE Time: 15:00-18:00 Daily (UK time)  Number of participants: Minimum 6 / Maximum 40  Course Title: A Hands-On Workshop to explore the clinical applications of Endogenous Biomarkers using PBPK  This workshop is ideal for those interested in developing PBPK models for endogenous biomarkers as sensitive and specific markers of ADME-related enzymes and transporters. Attendees will examine how these models assess metabolic and transporter-mediated DDI risk and how biomarkers can refine PBPK models for disease-state applications. Practical exercises will reinforce concepts and demonstrate the use of Simcyp features to develop effective endogenous biomarker models. Read more